3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Classical hematology
2
Conditions
Leukemia, Myeloid, Acute
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Neoplasms
29
Myelodysplastic Syndromes
24
Multiple Myeloma
22
Lymphoma, Non-Hodgkin
20
Anemia
20
Hodgkin Disease
19
Anemia, Refractory, with Excess of Blasts
19
Leukemia
18
Anemia, Aplastic
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Hematologic Neoplasms
17
Febrile Neutropenia
17
Venous Thromboembolism
16
Anemia, Sickle Cell
16
Lymphoma, Follicular
15
Myeloproliferative Disorders
14
Lymphoma, Mantle-Cell
14
Primary Myelofibrosis
13
Lymphoma
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Thrombocytopenia
11
Lymphoma, Large B-Cell, Diffuse
11
Burkitt Lymphoma
11
Leukemia, Myelomonocytic, Chronic
10
Leukemia, Myeloid, Chronic-Phase
10
Congenital Abnormalities
10
Neoplasms, Plasma Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Severe Combined Immunodeficiency
×
Classical hematology
×
Clear all
NCT05298930
2024-08-21
EVAADE
Centre Leon Berard
Phase NA
Completed
15 enrolled
NCT04331483
2022-02-28
EVAADE
Centre Leon Berard
Phase NA
Withdrawn